- Home
- XPEL vs RLAY Comparison
XPEL vs RLAY Comparison
Compare XPEL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPEL
- RLAY
- Stock Information
- Founded
- XPEL 1999
- RLAY 2015
- Country
- XPEL United States
- RLAY United States
- Employees
- XPEL N/A
- RLAY N/A
- Industry
- XPEL Industrial Specialties
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XPEL Industrials
- RLAY Health Care
- Exchange
- XPEL Nasdaq
- RLAY Nasdaq
- Market Cap
- XPEL 984.3M
- RLAY 803.4M
- IPO Year
- XPEL N/A
- RLAY 2020
- Fundamental
- Price
- XPEL $34.92
- RLAY $7.29
- Analyst Decision
- XPEL
- RLAY Strong Buy
- Analyst Count
- XPEL 0
- RLAY 8
- Target Price
- XPEL N/A
- RLAY $17.25
- AVG Volume (30 Days)
- XPEL 257.9K
- RLAY 1.9M
- Earning Date
- XPEL 11-05-2025
- RLAY 11-07-2025
- Dividend Yield
- XPEL N/A
- RLAY N/A
- EPS Growth
- XPEL 2.75
- RLAY N/A
- EPS
- XPEL 1.76
- RLAY N/A
- Revenue
- XPEL $448,897,000.00
- RLAY $8,355,000.00
- Revenue This Year
- XPEL $12.54
- RLAY $27.30
- Revenue Next Year
- XPEL $10.52
- RLAY $7.43
- P/E Ratio
- XPEL $20.20
- RLAY N/A
- Revenue Growth
- XPEL 9.96
- RLAY N/A
- 52 Week Low
- XPEL $24.25
- RLAY $1.78
- 52 Week High
- XPEL $47.23
- RLAY $7.64
- Technical
- Relative Strength Index (RSI)
- XPEL 49.79
- RLAY 66.79
- Support Level
- XPEL $35.42
- RLAY $6.30
- Resistance Level
- XPEL $37.71
- RLAY $7.64
- Average True Range (ATR)
- XPEL 0.99
- RLAY 0.46
- MACD
- XPEL 0.12
- RLAY 0.00
- Stochastic Oscillator
- XPEL 30.25
- RLAY 80.17
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).